I-Mab Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
/
Date11 Feb 2020
Email Print Friendly Share SHANGHAI, China and ROCKVILLE, MD., Feb. 10, 2020 (GLOBE NEWSWIRE) — I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company... Read More →
1Life Healthcare (One Medical) Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
/
Date08 Feb 2020
Email Print Friendly Share SAN FRANCISCO, Feb. 04, 2020 (GLOBE NEWSWIRE) — 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced the closing of its... Read More →
Warner Music Group Files Registration Statement for an Initial Public Offering
/
Date07 Feb 2020
Email Print Friendly Share NEW YORK, Feb. 06, 2020 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group”) today announced that it has filed... Read More →
Ceres Acquisition Corp. Files Preliminary Prospectus for Initial Public Offering of Units
/
Date06 Feb 2020
Email Print Friendly Share NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR OTHER DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 05, 2020 (GLOBE NEWSWIRE) — Ceres... Read More →
Nano Dimension Prices $3.5 Million Public Offering
/
Date05 Feb 2020
Email Print Friendly Share NESS ZIONA, ISRAEL , Feb. 04, 2020 (GLOBE NEWSWIRE) — Nano Dimension Ltd., a leading additive manufactured electronics (AME) provider (Nasdaq,... Read More →
Albireo Announces Closing of $46 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares
/
Date04 Feb 2020
Email Print Friendly Share BOSTON, Feb. 03, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile... Read More →
Annovis Bio Announces Pricing of Initial Public Offering
/
Date30 Jan 2020
Email Print Friendly Share BERWYN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) — Annovis Bio, Inc., a clinical stage, drug platform company addressing Alzheimer’s, Parkinson’s and... Read More →
Autolus Announces Closing of Public Offering
/
Date28 Jan 2020
Email Print Friendly Share LONDON, Jan. 27, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell... Read More →
Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
/
Date25 Jan 2020
Email Print Friendly Share PHILADELPHIA, Pa. and OXFORD, United Kingdom, Jan. 24, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in T-cell... Read More →
LIZHI INC. Announces Pricing of Initial Public Offering
/
Date19 Jan 2020
Email Print Friendly Share GUANGZHOU, China, Jan. 17, 2020 (GLOBE NEWSWIRE) — LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), a leading online UGC audio... Read More →